Miljan Pupovac

Mr. Miljan Pupovac


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
SRSvetlana Spremović Rađenović
Svetlana Spremović Rađenović
MPMiljan Pupovac
Miljan Pupovac
MAMladen Andjic
Mladen Andjic
JBJovan Bila
Jovan Bila
SSSvetlana Sreckovic
Svetlana Sreckovic
NRNebojša Radunović
Nebojša Radunović
Background: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders in women’s reproductive period of life. The presence of nonalcoholic fatty liver disease NAFLD, one of the leading causes of chronic liver disease in the Western world, is increased in women with PCOS. This review aims to present current knowledge in epidemiology, pathophysiology, diagnostics, and treatment of NAFLD in PCOS with an emphasis on the molecular basis of development of NAFLD in PCOS women. Methods: Authors investigated the available data on PCOS and NAFLD by a MEDLINE and Pub Med search during the years 1990–2021 using a combination of keywords such as “PCOS”, “NAFLD”, “steatohepatitis”, “insulin resistance”, “hyperandrogenaemia”, “inflammation”, “adipose tissue”, and “obesity”. Peer-reviewed articles regarding NAFLD and PCOS were included in this manuscript. Additional articles were identified from the references of relevant papers. Results: PCOS and NAFLD are multifactorial diseases, The development of NAFLD in PCOS women is linked to insulin resistance, hyperandrogenemia, obesity, adipose tissue dysfunction, and inflammation. There is the possible role of the gut microbiome, mitochondrial dysfunction, and endocannabinoid system in the maintenance of NAFLD in PCOS women. Conclusions: There is a need for further investigation about the mechanism of the development of NAFLD in PCOS women. New data about the molecular basis of development of NAFLD in PCOS integrated with epidemiological and clinical information could influence the evolution of new diagnostic and therapeutic approaches of NAFLD in PCOS.

Verified
Journal Article
Open access
PDF file
RSRadmila Sparic
Radmila Sparic
MAMladen Andjic
Mladen Andjic
IBIvana R Babovic
Ivana R Babovic
LNLazar Nejkovic
Lazar Nejkovic
MMMilena Mitrovic
Milena Mitrovic
ANDREA TINELLIANDREA TINELLI
ANDREA TINELLI
Uterine fibroids (UFs) are the most common benign tumors of female genital diseases, unlike uterine leiomyosarcoma (LMS), a rare and aggressive uterine cancer. This narrative review aims to discuss the biology and diagnosis of LMS and, at the same time, their differential diagnosis, in order to distinguish the biological and molecular origins. The authors performed a Medline and PubMed search for the years 1990–2022 using a combination of keywords on the topics to highlight the many genes and proteins involved in the pathogenesis of LMS. The mutation of these genes, in addition to the altered expression and functions of their enzymes, are potentially biomarkers of uterine LMS. Thus, the use of this molecular and protein information could favor differential diagnosis and personalized therapy based on the molecular characteristics of LMS tissue, leading to timely diagnoses and potential better outcomes for patients.

2 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
AGAleksandra Gudović
Aleksandra Gudović
ZBZoran Bukumiric
Zoran Bukumiric
Milos Nemanja MilincicMilos Nemanja Milincic
Milos Nemanja Milincic
MPMiljan Pupovac
Miljan Pupovac
MAMladen Andjic
Mladen Andjic
SRSvetlana Spremović Rađenović
Svetlana Spremović Rađenović
Background: Polycystic ovary syndrome (PCOS) is a multisystem reproductive–metabolic disorder and the most common endocrine cause of infertility. The objective of our study was to determine the influence of myo-inositol (MI) on insulin resistance (IR), menstrual cycle regularity, and hyperandrogenism in women suffering from PCOS with normal BMI and diagnosed IR. Methods: We performed a prospective randomized controlled trial (RCT) that included 60 participants with PCOS who had IR and a normal BMI. Two groups were formed. A group of thirty patients received MI, and thirty patients in the control group received metformin (MET). Results: A statistically significant reduction in the area under the curve (AUC) of insulin values during the oral glucose tolerance test (OGTT) was recorded in both examined groups after the applied therapy with MI and MET. The regularity of the menstrual cycle in both groups was improved in >90% of patients. A statistically significant decrease in androgenic hormones (testosterone, SHBG, free androgen index—FAI, androstenedione) was recorded in both groups and did not differ between the groups. Conclusions: Both MI and MET can be considered very effective in the regulation of IR, menstrual cycle irregularities, and hyperandrogenism in women with PCOS.

9 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJovan Bila
Jovan Bila
JDJelena Dotlic
Jelena Dotlic
MAMladen Andjic
Mladen Andjic
KIKatarina Ivanovic
Katarina Ivanovic
JMJelena Micic
Jelena Micic
SIStefan Ivanovic
Stefan Ivanovic
Background/Objectives: Polycystic Ovary Syndrome (PCOS), as a multifactorial chronic disease, can cause heterogeneous metabolic, physical, and psychological disorders as well as infertility in both obese and non-obese patients. Therefore, this review aimed to present differences in pathophysiology, clinical presentation, and therapy in obese and non-obese patients with PCOS. Methods: A non-systematic review was conducted by searching papers published in English from 2010 to 2024 in MEDLINE. Results: Obesity in PCOS significantly contributes to IR and worsens metabolic dysfunction. Lifestyle modifications, including a balanced diet and regular exercise, are the first line of treatment. Pharmacological therapies, such as metformin, GLP-1 receptor agonists, myoinositol, and resveratrol, are used to improve insulin sensitivity, regulate the hormonal milieu, and reduce hyperandrogenism. Metformin is widely used to improve glucose metabolism and reduce androgen levels, while myoinositol is effective in promoting ovarian function. GLP-1 receptor agonists and resveratrol improve metabolic and reproductive outcomes. For patients with severe obesity, bariatric surgery offers substantial improvements in body composition, metabolic function, and fertility. Combination therapies, such as metformin and GLP-1 receptor agonists, provide comprehensive treatment for both reproductive and metabolic aspects of PCOS. Conclusions: The first-line treatment for PCOS is a lifestyle-modifying strategy. PCOS patients with insulin resistance and obesity would mostly benefit from combination therapy with metformin and GLP-1 receptor agonists.

7 February 2023 in Medicina
Verified
Journal Article
Open access
PDF file
JSJelena Dusan Stojnic
Jelena Dusan Stojnic
JBJovan Bila
Jovan Bila
LTLidija Tulic
Lidija Tulic
JMJelena Micic
Jelena Micic
MAMladen Andjic
Mladen Andjic
JDJelena Dotlic
Jelena Dotlic
Background and Objectives: Severe hemoperitoneum of ovarian bleeding origin is a rare but potentially life-threatening complication of transvaginal oocyte retrieval (TVOR) procedure. The study aimed to present a case series of surgically managed patients from our clinic with hemoperitoneum caused by ovarian bleeding after TVOR, as well as to perform a comprehensive literature review in order to summarize and analyze all published cases with this condition and their management. Materials and Methods: The data of 2939 patients, who underwent TVOR procedures for IVF/ICSI (in vitro fertilization, intracytoplasmic sperm injection) in our clinic between 2010 and 2021 were reviewed. Moreover, a systemic literature search was performed. Main outcome measures from the pooled analysis were incidence and risk factors, type of surgery, intraoperative finding and intervention leading to hemostasis. Results: In our Clinic 4 (0.136%), cases of hemoperitoneum due to ovarian bleeding were surgically managed. Moreover, 39 cases from 18 studies reported in the literature were identified. No risk factors besides lean women with PCOS were identified. In the pooled analysis, the bleeding symptoms appeared in 58.1% of patients within eight hours after TVOR and cumulatively in 81.4% cases during the 24 h after TVOR. The average time from TVOR to surgery was 27.19 ± 53.25 h. Hemostasis was mostly established using electrocoagulation, although few cases of ovariectomy were also reported. Embryo transfer at 60% of cases was postponed and embryos cryopreserved. Conclusions: Severe hemoperitoneum due to ovarian bleeding after TVOR is a rare event that should be treated by techniques of minimally invasive surgery whenever possible. Protocols should be developed to enable optimal management strategies for infertility patients. Embryos obtained should be cryopreserved.

1 January 2021 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
SRSvetlana Spremović Rađenović
Svetlana Spremović Rađenović
MPMiljan Pupovac
Miljan Pupovac
Background/Aim. Insulin resistance occurs in approximately 60?80% of women with polycystic ovary syndrome (PCOS) and in 95% of obese women with PCOS. Previous studies have shown that the shape of the glucose curve obtained during an oral glucose tolerance test (OGTT) may be useful as a metabolic screening parameter and could give in-sight into the future risk of diabetes mellitus type II. The aim of this study was to determine the frequency of insulin resistance according to the Homeostasis model assessment of insulin resistance (HOMA-IR) and indirect assessment method of insulin resistance based on insulinemias during the oral glucose tolerance test (OGTT) (here in after ?insulinemias during the OGTT?), as well as, frequency of glucose curve shapes (monophasic, biphasic, triphasic) in patients with PCOS. Also, the aim of research was testing the correlation between glucose curve shape and peak time of glucose during the OGTT with presence of insulin resistance in patients with PCOS. Methods. Patients were observed according to the following parameters: presence of insulin resistance, glucose curve shape and peak time of glucose and insulin during the OGTT. Results. The observed prevalence of insulin resistance in the PCOS group according to the HOMA-IR > 2.5 was 66.19% and according to insulinemias during the OGTT was 78.42%. The shape of the glucose curve was monophasic in 293 (70.26%), biphasic in 56 (13.43%) and triphasic in 68 (16.31%) of patients. There was statistically significant difference in the frequency of insulin resistance, according to glucose curve shape, only when it was defined by insulinemias during the OGTT (p = 0.005). Conclusion. According to results of the study, the most patients with PCOS have a monophasic shape of glucose curve. When we take frequency of insulin resistance in account, we notice approximately the same frequency in all types of curves, when it is defined by the HOMA-IR. On the other hand, when insulin resistance is defined by insulinemias during the OGTT, resistant patients with PCOS mostly have triphasic glucose curve shape.